Whole-exome sequencing of schizophrenia in an underrepresented indigenous population of Northeast India: Rare coding variant burden and clinical correlates.
Oct 2026· Asian Journal of Psychiatry· Vol 125, pp.
105176
· 0 citations· 95 references
Medicine
TL;DR
This first whole-exome study of schizophrenia in the Indigenous Mizo population provides preliminary evidence of increased rare damaging coding-variant burden and negative-symptom severity, supporting the involvement of synaptic and neurodevelopmental disturbances in an underrepresented Indigenous population.
Abstract
Schizophrenia is a severe mental disorder, and emerging evidence suggests that neurodevelopmental and synaptic dysfunction are critical factors in the pathogenesis of the disorder. This study investigated schizophrenia-related genetic variation in the genetically distinct and endogamous Mizo population of Northeast India using whole-exome sequencing. Twenty individuals with schizophrenia and 27 healthy controls were analysed. A panel gene consisting 95 gene associated with schizophrenia was initially used for descriptive profiling and pathway dysregulation, whereas an expanded 239-gene neuropsychiatric panel was used for standardized case-control analysis, recurrent and clinically significant variants and rare damaging effects. The descriptive analysis identified 321 variants across 32 genes, with recurrent variants most frequently observed in PCLO and RELN (100%), NRG1 (95%), CACNA1B (90%), BRCA1 (85%), and APOE and PLXNA2 (80%). Pathogenicity analysis revealed recurrent variants with conflicting pathogenic classifications in CNTNAP2, VDR, APOE, CHD8, and ERBB4. In the standardized case-control analysis, patients carried a significantly higher burden of rare damaging coding SNVs than controls. The synaptic burden score was positively correlated with PANSS negative-symptom severity, whereas its association with PANSS positive symptoms was not significant. Pathway analysis highlighted significant involvement of MAPK signalling, dopaminergic synapse, neuroactive ligand-receptor interaction and GABAergic synapse pathways. Overall, this first whole-exome study of schizophrenia in the Indigenous Mizo population provides preliminary evidence of increased rare damaging coding-variant burden and negative-symptom severity, supporting the involvement of synaptic and neurodevelopmental disturbances in an underrepresented Indigenous population.
Together, these results implicate a constellation of rare variants that map onto neuronal biology and demonstrate that diverse global populations converge on shared genetic signals underlying BD risk.
Calwing Liao, Robert Ye, J. Sealock et al.· medRxiv· 0 citations
Constraint-weighted rare variant load contributes measurably to cognitive and neuropsychiatric outcomes in population cohorts, particularly among people with autism spectrum disorder and related conditions.
M. Ahangari, S. Moore, J. Schleede et al.· medRxiv· 0 citations
Schizophrenia liability reflects both common polygenic variation and rarer variants of larger effect. We investigated a post-mortem schizophrenia case (SZ07) with a schizophrenia polygenic risk score below the first percentile among ancestry-matched cases, asking whether individual-level genomic and transcriptomic anal...
N. Kondratyev, A. Artyuhov, V. A. Guven et al.· bioRxiv· 0 citations
A Kazakhstani family with 9-year-old monozygotic twin girls who developed focal seizures with secondary generalization at approximately one year of age and were subsequently diagnosed with ASD is described, illustrating the distinction between candidate variants and a molecular diagnosis.
A. Gabdulkayum, Z. Mirmanova, A. Daniyarov et al.· Eurasian journal of applied...· 0 citations
Epilepsy ranks among the most prevalent neurological disorders globally, with a substantial proportion of cases, particularly in pediatric populations, attributed to genetic etiologies. This study provides the first molecular characterization of suspected genetic epilepsy in a pediatric cohort from the Moldova region o...
L. Butnariu, Ecaterina Grigore, T. Schreiner et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.